CS logo
small CS logo
Gelre Ziekenhuizen

Apeldoorn, Netherlands
Hospital in Apeldoorn
Albert Schweitzerlaan 31, 7334 DZ Apeldoorn

About Gelre Ziekenhuizen


"Gelre ziekenhuizen, ontstaan vanuit een fusie in 1999, kent een relatief korte historie. We teren echter op een rijk en divers verleden. Inmiddels zijn we een begrip waar het gaat over het verlenen van de juiste medisch specialistische zorg. Met meer dan 3.600 betrokken medewerkers, van medisch specialist tot vrijwilliger, werken we elke dag aan een betere gezondheid voor de 350.000 mensen in ons verzorgingsgebied. Op die manier zijn we figuurlijk én letterlijk (in) het hart van de zorg in onze regio. Daarnaast vervullen we vanuit onze specifieke kennis en kunde op een aantal medische gebieden een bovenregionale functie."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Radboud University Medical Center
16
Boehringer Ingelheim
11
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
7
European Organisation for Research and Treatment of Cancer - EORTC
6
UMC Utrecht
6
Borstkanker Onderzoek Groep
5
The Netherlands Cancer Institute
5
Janssen Research & Development, LLC
4
Amgen
3
Amsterdam UMC, location VUmc
3
Bayer
3
Total Rows: 57

Clinical Trials at Gelre Ziekenhuizen


During the past decade, Gelre Ziekenhuizen conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 18 clinical trials were completed, i.e. on average, 25.7% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 9 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years6699121210106613134410100011224422114422Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
1998-08-01
Completed
450
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
1999-02-01
Terminated
158
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer
2001-02-01
2013-03-01
Completed
4,813
Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer
2001-04-01
Terminated
5
J-Pouch Coloanal Anastomosis Compared With Side-to-End Coloanal Anastomosis After Radiation Therapy and Surgery to Remove the Rectum in Treating Patients With Rectal Adenocarcinoma
2002-06-01
Unknown status
100
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
2003-11-01
2008-07-01
Completed
505
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
2004-03-01
Completed

Rows per page:

1–100 of 129

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Gelre Ziekenhuizen" #1 sponsor was "Radboud University Medical Center" with 16 trials, followed by "Boehringer Ingelheim" with 11 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 7 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored and "UMC Utrecht" with 6 trials sponsored. Other sponsors include 78 different institutions and companies that sponsored additional 57 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gelre Ziekenhuizen" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 16 trials as a collaborator, "Amsterdam UMC, location VUmc" with 6 trials as a collaborator, "Eli Lilly and Company" with 6 trials as a collaborator, "Borstkanker Onderzoek Groep" with 4 trials as a collaborator and "Dutch Cancer Society" with 4 trials as a collaborator. Other collaborators include 141 different institutions and companies that were collaborators in the rest 121 trials.
Created with Highcharts 11.1.0Top Leading SponsorsRadboud UniversityMedical Center: 16Radboud UniversityMedical Center: 16Boehringer Ingelheim: 11Boehringer Ingelheim: 11Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 7Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 7European Organisationfor Research andTreatment of Cancer -EORTC: 6European Organisationfor Research andTreatment of Cancer -EORTC: 6UMC Utrecht: 6UMC Utrecht: 6Borstkanker OnderzoekGroep: 5Borstkanker OnderzoekGroep: 5The Netherlands CancerInstitute: 5The Netherlands CancerInstitute: 5Janssen Research &Development, LLC: 4Janssen Research &Development, LLC: 4Amgen: 3Amgen: 3Amsterdam UMC,location VUmc: 3Amsterdam UMC,location VUmc: 3

Created with Highcharts 11.1.0Top CollaboratorsZonMw: TheNetherlandsOrganisation for HealthResearch andDevelopment: 16ZonMw: TheNetherlandsOrganisation for HealthResearch andDevelopment: 16Amsterdam UMC,location VUmc: 6Amsterdam UMC,location VUmc: 6Eli Lilly and Company: 6Eli Lilly and Company: 6Borstkanker OnderzoekGroep: 4Borstkanker OnderzoekGroep: 4Dutch Cancer Society: 4Dutch Cancer Society: 4Erasmus Medical Center: 4Erasmus Medical Center: 4Gelre Hospitals: 4Gelre Hospitals: 4Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 3Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 3Dutch Society ofPhysicians forPulmonology andTuberculosis: 3Dutch Society ofPhysicians forPulmonology andTuberculosis: 3Gilead Sciences: 3Gilead Sciences: 3

Clinical Trials Conditions at Gelre Ziekenhuizen


According to Clinical.Site data, the most researched conditions in "Gelre Ziekenhuizen" are "Heart Failure" (6 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Lung Cancer" (4 trials) and "Pulmonary Disease, Chronic Obstructive" (4 trials). Many other conditions were trialed in "Gelre Ziekenhuizen" in a lesser frequency.

Clinical Trials Intervention Types at Gelre Ziekenhuizen


Most popular intervention types in "Gelre Ziekenhuizen" are "Drug" (78 trials), "Other" (24 trials), "Procedure" (23 trials), "Radiation" (6 trials) and "Behavioral" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (23 trials), "Empagliflozin" (5 trials), "Filgotinib" (4 trials), "cisplatin" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Gelre Ziekenhuizen


The vast majority of trials in "Gelre Ziekenhuizen" are 115 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Gelre Ziekenhuizen


Currently, there are 46 active trials in "Gelre Ziekenhuizen". 1 are not yet recruiting, 27 are recruiting, 15 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 51 completed trials in Gelre Ziekenhuizen, 1 suspended trials, and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Gelre Ziekenhuizen, 0 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 23 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 46Phase 3: 46Phase 2: 24Phase 2: 24Not Applicable: 23Not Applicable: 23Phase 4: 15Phase 4: 15

Created with Highcharts 11.1.0Trials StatusCompleted: 51Completed: 51Recruiting: 27Recruiting: 27Active, not recruiting: 15Active, not recruiting: 15Terminated: 15Terminated: 15Unknown status: 14Unknown status: 14Enrolling by invitation: 3Enrolling by invitation: 3Withdrawn: 2Withdrawn: 2Not yet recruiting: 1Not yet recruiting: 1Suspended: 1Suspended: 1